sRANKL antibody [IK22/5]

GeneTex

sRANKL antibody [IK22/5]

9

BL: Use at an assay dependent dilution. The Low Endotoxin Azide Free format is suggested for blocking studies. FACS: Use 0.5microg for 10^6 cells 100microl volume. IP: Use at an assay dependent dilution. WB: Use at an assay dependent dilution. Predicted molecular weight: 35 kDa. Optimal dilutions/concentrations should be determined by the end user.

Flow Cytometry, ImmunoPrecipitation, Western Blot, Neutralisation/Blocking

Research Use Only

Monoclonal

IK22/5

0.5 mg/ml

Unconjugated

Tnfsf11

tumor necrosis factor (ligand) superfamily, member 11

Ly10; Ly109l; O; OD; ODF; OPG ligand; OPGL; osteoclast differentiation factor; osteoprotegerin ligand; R; RANKL; receptor activator of NF-kappaB ligand; receptor activator of nuclear factor kappa-B ligand; TNF-related activation-induced cytokine; Tra; Trance; tumor necrosis factor ligand superfamily member 11; tumor necrosis factor-related activation-induced cytokine

Rat

IgG2a

Tumor necrosis factor ligand superfamily member 11

-20°C or -80°C,2°C to 8°C

12352203